The ASCENT project in the Philippines
The Philippines is one of the five countries where the ASCENT project is implemented. Over 90 health care facilities in the Bulacan Province, Pampanga Province and the National Capital Region are participating in the project. Patients and health care workers will make use of digital adherence technologies to support the former upon taking their daily TB medication at home, at work, or any venue of their choice. The first patients will be enrolled in 2020.
The Philippines has a population of 107 million people and is one of the 30 high TB burden countries in the world, as listed by the World Health Organization (WHO Global Tuberculosis Report,2019). In 2018, an estimated 591,000 people suffered from TB in the Philippines, giving a TB incidence rate of 554 per 100,000 population. An estimated 18,000 people suffered from multidrug-resistant TB. The WHO estimates 27,000 people died of TB in the Philippines.
news & Stories from the Philippines
KNCV ramps up support for the expanded use of digital adherence technology in the Philippines
PBSP will expand the use of the smart pillbox for tuberculosis (TB) treatment in the Philippines. To jumpstart the scale-up, KNCV is providing technical support to PBSP.
The smart pillbox carves a path to better tuberculosis management and cure
A first person account on how digital adherence technology can help reinforce medication adherence, in a way that benefits the patient and enhances health system efficiency.
ASCENT Philippines concludes digital adherence technology implementation activities; DAT scale-up assured in 2023
ASCENT concluded digital adherence technology (DAT) implementation activities in the Philippines. PBSP will expand DAT use nationwide.
Philippines scales up ASCENT’s implementation of digital technology for tuberculosis treatment
The ASCENT project will phase out in December 2022. The Philippines, however, will expand the use of digital adherence technology across the country in 2023.